Results 101 to 110 of about 1,129 (187)

Azilsartan medoxomil/chlorthalidone – a new effective antihypertensive combination

Cardiology: News, Opinions, Training, 2022
E.K. Serezhina, A.G. Obrezan
openaire   +1 more source

Rationalisierung und Wettbewerb im Arzneimittelmarkt [PDF]

, 2012
Rationalisierungsmaßnahmen sind bei steigenden Ausgaben in einem vor allem durch Umlagen finanzierten Gesundheitssystem wichtige Mittel zur Erreichung einer effizienten Produktion und Allokation der Ressourcen.
Herr, Annika
core  

Development and Validation of Stability Indicating UPLC Method for Simultaneous Determination of Olmesartan Medoxomil and Chlorthalidone in Bulk and Pharmaceutical Dosage Form [PDF]

Aim: The establishment and validation of simultaneous determination of Olmesartan medoxomil and chlorthalidone by UPLC according to ICH guidelines ensure that the analytical method meets regulatory standards and can be used effectively for quantitative ...
Lavanya. K, Chaithanya Sudha. P. D, M. K. Ranganath, Ramesh G, Kavitha
core   +2 more sources

Rapid LC-MS Compatible Stability Indicating Assay Method for Azilsartan Medoxomil Potassium

Journal of Analytical & Bioanalytical Techniques, 2015
Azilsartan medoxomil potassium is a new generation antihypertensive drug comes under class of angiotensin receptor blockers. The present study focuses on developing a liquid chromatography-mass spectrometry compatible stability indicating assay method for determination of azilsartan medoxomil potassium in bulk drug and formulations. In order to develop
openaire   +1 more source

Artificial Intelligence Approach in Machine Learning-Based Modeling and Networking of the Coronavirus Pathogenesis Pathway [PDF]

The coronavirus pathogenesis pathway, which consists of severe acute respiratory syndrome (SARS) coronavirus infection and signaling pathways, including the interferon pathway, the transforming growth factor beta pathway, the mitogen-activated protein ...
Cabral, Horacio, Kojima, Motohiro, Ono, Ryuichi, Perkins, Edward J., Quader, Sabina, Tanabe, Shihori, Tanaka, Hiroyoshi Y., Yamamoto, Akihisa   +7 more
core   +1 more source

A phase 3 double-blind randomized (CONSORT-compliant) study of azilsartan medoxomil compared to valsartan in Chinese patients with essential hypertension. [PDF]

Medicine (Baltimore), 2020
Wu J, Du X, Lv Q, Li Z, Zheng Z, Xia Y, Tang C, Yao Z, Zhang J, Long M, Hisada M, Wu J, Zhou W, Ma C.   +13 more
europepmc   +1 more source

558 AZILSARTAN MEDOXOMIL VS OLMESARTAN AND VALSARTAN

Journal of Hypertension, 2012
Stuart Kupfer, William B. White, Michael A. Weber, Domenic Sica, George L. Bakris, Eric Song, Alison Handley   +6 more
openaire   +2 more sources

Design And Development Of Azilsartan Medoxomil Solid Self Microemulsifying Drug Delivery System

Nanotechnology Perceptions
Design and development of Azilsartan Medoxomil solid Self Microemulsifying drug delivery system. The selection of oil, surfactant and co-surfactant was carried out using screening study. AM is more soluble in castor oil, tween-20 and carbitol. The solubility was found to be 19.63±0.08 mg/ml, 80.56±0.125 mg/ml and 83.62±0.165 mg/ml in olive oil, tween ...
Asha Praveen, Surendra Pratap Singh, Sunil Kumar Shah, Jitendra Kumar Malik   +3 more
openaire   +1 more source

Azilsartana para o tratamento de hipertensão arterial [PDF]

, 2015
análise independente de novo fármaco ...
CFF, Cebrim
core   +1 more source

Efficacy and safety of different doses of azilsartan medoxomil in patients with hypertension: A protocol of a network meta-analysis. [PDF]

Medicine (Baltimore), 2019
Zhang Y, Yu H, Shao K, Luo X, Wang J, Chen G.   +5 more
europepmc   +1 more source